Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer - Drug Trials For Money - Paid Clinical Trials

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
Conditions:   Advanced Bile Duct Carcinoma;   Advanced Breast Carcinoma;   Advanced Cervical Carcinoma;   Advanced Endometrial Carcinoma;   Advanced Esophageal Carcinoma;   Advanced Gastric Carcinoma;   Advanced Head and Neck Carcinoma;   Advanced Lung Non-Small Cell Carcinoma;   Advanced Lung Small Cell Carcinoma;   Advanced Malignant Solid Neoplasm;   Advanced Ovarian Carcinoma;   Advanced Penile Carcinoma;   Advanced Pleural Malignant Mesothelioma;   Advanced Urothelial Carcinoma;   Anatomic Stage III Breast Cancer AJCC v8;   Anatomic Stage IIIA Breast Cancer AJCC v8;   Anatomic Stage IIIB Breast Cancer AJCC v8;   Anatomic Stage IIIC Breast Cancer AJCC v8;   Anatomic Stage IV Breast Cancer AJCC v8;   Clinical Stage III Gastric Cancer AJCC v8;   Clinical Stage IV Gastric Cancer AJCC v8;   Clinical Stage IVA Gastric Cancer AJCC v8;   Clinical Stage IVB Gastric Cancer AJCC v8;   Pathologic Stage III Gastric Cancer AJCC v8;   Pathologic Stage IIIA Gastric Cancer AJCC v8;   Pathologic Stage IIIB Gastric Cancer AJCC v8;   Pathologic Stage IIIC Gastric Cancer AJCC v8;   Pathologic Stage IV Gastric Cancer AJCC v8;   Prognostic Stage III Breast Cancer AJCC v8;   Prognostic Stage IIIA Breast Cancer AJCC v8;   Prognostic Stage IIIB Breast Cancer AJCC v8;   Prognostic Stage IIIC Breast Cancer AJCC v8;   Prognostic Stage IV Breast Cancer AJCC v8;   Stage III Cervical Cancer AJCC v8;   Stage III Distal Bile Duct Cancer AJCC v8;   Stage III Intrahepatic Bile Duct Cancer AJCC v8;   Stage III Lung Cancer AJCC v8;   Stage III Ovarian Cancer AJCC v8;   Stage III Penile Cancer AJCC v8;   Stage III Pleural Malignant Mesothelioma AJCC v8;   Stage IIIA Cervical Cancer AJCC v8;   Stage IIIA Distal Bile Duct Cancer AJCC v8;   Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8;   Stage IIIA Lung Cancer AJCC v8;   Stage IIIA Ovarian Cancer AJCC v8;   Stage IIIA Penile Cancer AJCC v8;   Stage IIIA Pleural Malignant Mesothelioma AJCC v8;   Stage IIIA1 Ovarian Cancer AJCC v8;   Stage IIIA2 Ovarian Cancer AJCC v8;   Stage IIIB Cervical Cancer AJCC v8;   Stage IIIB Distal Bile Duct Cancer AJCC v8;   Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8;   Stage IIIB Lung Cancer AJCC v8;   Stage IIIB Ovarian Cancer AJCC v8;   Stage IIIB Penile Cancer AJCC v8;   Stage IIIB Pleural Malignant Mesothelioma AJCC v8;   Stage IIIC Lung Cancer AJCC v8;   Stage IIIC Ovarian Cancer AJCC v8;   Stage IV Cervical Cancer AJCC v8;   Stage IV Distal Bile Duct Cancer AJCC v8;   Stage IV Intrahepatic Bile Duct Cancer AJCC v8;   Stage IV Lung Cancer AJCC v8;   Stage IV Ovarian Cancer AJCC v8;   Stage IV Penile Cancer AJCC v8;   Stage IV Pleural Malignant Mesothelioma AJCC v8;   Stage IVA Cervical Cancer AJCC v8;   Stage IVA Lung Cancer AJCC v8;   Stage IVA Ovarian Cancer AJCC v8;   Stage IVB Cervical Cancer AJCC v8;   Stage IVB Lung Cancer AJCC v8;   Stage IVB Ovarian Cancer AJCC v8;   Triple-Negative Breast Carcinoma;   Unresectable Urothelial Carcinoma
Interventions:   Drug: Cisplatin;   Drug: Elimusertib;   Drug: Gemcitabine Hydrochloride
Sponsor:   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 7, 2021 / by / in
Comments